Healthcare resource use in schizophrenia, EuroSC findings. Issue 1 (1st January 2017)

• Record Type: Journal Article
• Authors: Millier, A.; Horváth, M.; Ma, F.; Kóczián, K.; Götze, A.; Toumi, M.
• Is Part Of: Journal of market access & health policy. Volume 5:Issue 1(2017)
• Publication Date: 2017-01-01
• Subjects: Schizophrenia -- resource use -- hospitalisation -- outpatient visits -- negative symptoms -- EuroSC; Medical policy -- Periodicals; Medical policy -- Economic aspects -- Periodicals; International trade -- Environmental aspects -- Periodicals; Health Policy -- economics; Technology Assessment, Biomedical; Marketing of Health Services; International trade -- Environmental aspects; Medical policy; Periodicals; Periodicals; Fulltext; Internet Resources; Periodicals; 362.1
• DOI: 10.1080/20016689.2017.1372027
• Languages: English
• ISSNs: 2001-6689

Abstract

ABSTRACT: Background : It is unclear if the burden associated with schizophrenia is affected by the type and severity of patient's symptoms. Objective : This study aims to quantify healthcare resource use associated with different profiles of schizophrenia symptoms. Study design : Post-hoc analysis of data from a naturalistic follow-up study. Setting : Secondary psychiatric services in France, Germany and the UK. Patients : EuroSC cohort:, representative sample of 1, 208 schizophrenia patients Main outcome measure : We classified patients into eight health states, according to the Lenert classification (HS1–HS8), and estimated 6-month healthcare resource use (outpatient and day clinic visits, and hospitalisations) across the health states. Results : Approximately half of the patients were classed as having mild symptoms (HS1), with around 20% experiencing moderate, predominantly negative symptoms (HS2). The remaining health states were represented by <10% of patients each. Very few patients experienced extremely severe symptoms (HS8). No health state was associated with excess utilisation across all resource types. In terms of outpatient visits, patients were estimated to see a psychiatrist most often (3.01–4.15 visits over 6 months). Hospital admission was needed in 11%(HS1) – 35%(HS8) of patients and inpatient stays were generally prolonged for all health states (39–57 days). The average number of inpatient days was highest for patients in HS8 (18.17 days), followed by patients with severe negative symptoms (HS4; 13.37 days). In other health states characterised by severe symptoms (HS5–HS7), the average number of inpatient days was approximately half of those seen for HS4 (6.09–7.66). Conclusion : While none of the symptom profiles was associated with excess resource usage, hospitalization days were highest for HS with severe, predominantly negative or extremely severe symptoms. Patients with predominantly negative, moderate or severe symptoms appeared to have a high number of psychologist visits – an interesting finding that may reflect a specific therapeutic approach to the treatment of these patients.